Literature DB >> 3710693

Complete covalent structure of a proline-rich phosphoprotein, PRP-2, an inhibitor of calcium phosphate crystal growth from human parotid saliva.

D H Schlesinger, D I Hay.   

Abstract

Human salivary secretions contain many proteins in which proline forms an unusually large fraction of the amino-acid residues present, typically from 20% to over 40%. These proteins are also unusually rich in glycine and glutamine, generally account for over half the total protein in saliva, and include acidic, basic and glycosylated molecules. The functions of most of these are not clearly defined. One group, however, the acidic proline-rich phosphoproteins (PRP), have been shown to be potent inhibitors of secondary precipitation (crystal growth) of calcium phosphate salts. Acting together with a salivary protein inhibitor of primary precipitation of calcium phosphates, statherin, the PRP stabilize saliva which is supersaturated with respect to the calcium phosphate salts which form dental enamel. These inhibitory activities act to provide a protective, reparative, but stable environment for dental enamel, which is important for maintaining the health of the teeth. The PRP are a complex group of phosphoproteins which include four major and at least eight minor members. The primary structures of three of the major proteins have been determined. These are PRP-1, also designated Protein-C, PRP-3, also designated Protein-A (17), and PRP-4. The designations PRP-1,-2,-3 and -4 will be used here. The purpose of this paper is to report the complete primary structure of PRP-2 as a further step towards establishing the structural basis of the biological activity of the PRP, and clarifying the genetic and biosynthetic relationships of these closely related proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710693     DOI: 10.1111/j.1399-3011.1986.tb01030.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  9 in total

1.  Large-scale purification and characterization of the major phosphoproteins and mucins of human submandibular-sublingual saliva.

Authors:  N Ramasubbu; M S Reddy; E J Bergey; G G Haraszthy; S D Soni; M J Levine
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Adsorbed salivary proline-rich protein 1 and statherin: receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on apatitic surfaces.

Authors:  R J Gibbons; D I Hay; J O Cisar; W B Clark
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

3.  The primary structures of six human salivary acidic proline-rich proteins (PRP-1, PRP-2, PRP-3, PRP-4, PIF-s and PIF-f).

Authors:  D I Hay; A Bennick; D H Schlesinger; K Minaguchi; G Madapallimattam; S K Schluckebier
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

Review 4.  The functions of saliva.

Authors:  M D Kaplan; B J Baum
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

5.  Inhibition of calcium phosphate precipitation by human salivary acidic proline-rich proteins: structure-activity relationships.

Authors:  D I Hay; E R Carlson; S K Schluckebier; E C Moreno; D H Schlesinger
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

6.  Delineation of a segment of adsorbed salivary acidic proline-rich proteins which promotes adhesion of Streptococcus gordonii to apatitic surfaces.

Authors:  R J Gibbons; D I Hay; D H Schlesinger
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces.

Authors:  R J Gibbons; D I Hay
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

8.  Primary structure and possible origin of the non-glycosylated basic proline-rich protein of human submandibular/sublingual saliva.

Authors:  R Robinson; D L Kauffman; M M Waye; M Blum; A Bennick; P J Keller
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

Review 9.  Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Authors:  Raymond Farah; Hayat Haraty; Ziad Salame; Youssef Fares; David M Ojcius; Najwane Said Sadier
Journal:  Biomed J       Date:  2018-05-10       Impact factor: 4.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.